Your browser doesn't support javascript.
loading
Differences in splicing defects between the grey and white matter in myotonic dystrophy type 1 patients.
Nishi, Masamitsu; Kimura, Takashi; Igeta, Masataka; Furuta, Mitsuru; Suenaga, Koichi; Matsumura, Tsuyoshi; Fujimura, Harutoshi; Jinnai, Kenji; Yoshikawa, Hiroo.
Affiliation
  • Nishi M; Department of Internal Medicine Division of Neurology, Hyogo College of Medicine, Nishinomiya, Japan.
  • Kimura T; Department of Internal Medicine Division of Neurology, Hyogo College of Medicine, Nishinomiya, Japan.
  • Igeta M; Department of Biostatistics, Hyogo College of Medicine, Nishinomiya, Japan.
  • Furuta M; Department of Neurology, Japan Organization of Occupational Health and Safety Kan-sai Rosai Hospital, Osaka, Japan.
  • Suenaga K; Department of Internal Medicine Division of Neurology, Hyogo College of Medicine, Nishinomiya, Japan.
  • Matsumura T; Department of Internal Medicine, Japan Self Defense Force Hanshin Hospital, Kawanishi, Japan.
  • Fujimura H; Department of Neurology, National Hospital Organization Toneyama Hospital, Toyonaka, Japan.
  • Jinnai K; Department of Neurology, National Hospital Organization Toneyama Hospital, Toyonaka, Japan.
  • Yoshikawa H; Department of Neurology, National Hospital Organization Hyogo-Chuo Hospital, Sanda, Japan.
PLoS One ; 15(5): e0224912, 2020.
Article in En | MEDLINE | ID: mdl-32407311
ABSTRACT
Myotonic dystrophy type 1 (DM1) is a multi-system disorder caused by CTG repeats in the myotonic dystrophy protein kinase (DMPK) gene. This leads to the sequestration of splicing factors such as muscleblind-like 1/2 (MBNL1/2) and aberrant splicing in the central nervous system. We investigated the splicing patterns of MBNL1/2 and genes controlled by MBNL2 in several regions of the brain and between the grey matter (GM) and white matter (WM) in DM1 patients using RT-PCR. Compared with amyotrophic lateral sclerosis (ALS, as disease controls), the percentage of spliced-in parameter (PSI) for most of the examined exons were significantly altered in most of the brain regions of DM1 patients, except for the cerebellum. The splicing of many genes was differently regulated between the GM and WM in both DM1 and ALS. In 7 out of the 15 examined splicing events, the level of PSI change between DM1 and ALS was significantly higher in the GM than in the WM. The differences in alternative splicing between the GM and WM may be related to the effect of DM1 on the WM of the brain.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA-Binding Proteins / Alternative Splicing / Gray Matter / White Matter / Myotonic Dystrophy Limits: Adult / Female / Humans / Male Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2020 Document type: Article Affiliation country: Japón

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: RNA-Binding Proteins / Alternative Splicing / Gray Matter / White Matter / Myotonic Dystrophy Limits: Adult / Female / Humans / Male Language: En Journal: PLoS One Journal subject: CIENCIA / MEDICINA Year: 2020 Document type: Article Affiliation country: Japón